The improvements seen among patients who received the therapy continued after the treatment period ended, providing early evidence that noninvasive biophysical approaches may warrant further study as potential treatments for persistent neurological symptoms of long COVID.
“Cognitive symptoms are among the most persistent and disabling manifestations of long COVID, yet evidence-based treatment options have been sparse,” said Jacqueline Becker, Ph.D., a clinical neuropsychologist and assistant professor of medicine at the Icahn School of Medicine at Mount Sinai and co-senior author of the study.